Follow the 에이비프로바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Industrials sector, 에이비프로바이오 has published 53 public disclosures. Market capitalisation: €20.5bn. The latest transaction was reported on 27 May 2026 (Other). Among the most active insiders: 상상인저축은행. All data is openly available.
53
Insider Decl.
n/a
Thresholds
€2m
34 ops.
Buy Volume
n/a
2 ops.
Sell Volume
10Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Established in the industrial sector, 에이비프로바이오 is a company listed on the XKRX market. It specializes in the development of biopharmaceutical products.